A detailed history of Pallas Capital Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 5,134 shares of DXCM stock, worth $583,684. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,134
Previous 5,051 1.64%
Holding current value
$583,684
Previous $626,000 13.74%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$114.22 - $140.1 $9,480 - $11,628
83 Added 1.64%
5,134 $712,000
Q4 2023

Jan 22, 2024

SELL
$75.49 - $124.16 $1,887 - $3,104
-25 Reduced 0.49%
5,051 $626,000
Q3 2023

Nov 01, 2023

BUY
$86.06 - $137.93 $1,290 - $2,068
15 Added 0.3%
5,076 $473,000
Q2 2023

Jul 26, 2023

BUY
$112.47 - $130.98 $92,112 - $107,272
819 Added 19.31%
5,061 $650,000
Q1 2023

May 02, 2023

BUY
$104.0 - $122.92 $17,264 - $20,404
166 Added 4.07%
4,242 $492,000
Q4 2022

Jan 24, 2023

BUY
$84.98 - $122.67 $1,019 - $1,472
12 Added 0.3%
4,076 $0
Q3 2022

Nov 07, 2022

SELL
$76.35 - $94.18 $229 - $282
-3 Reduced 0.07%
4,064 $458,000
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $192,887 - $377,008
2,837 Added 230.65%
4,067 $341,000
Q1 2022

Apr 20, 2022

SELL
$94.08 - $130.2 $28,976 - $40,101
-308 Reduced 20.03%
1,230 $605,000
Q4 2021

Feb 01, 2022

SELL
$129.87 - $162.82 $6,883 - $8,629
-53 Reduced 3.33%
1,538 $649,000
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $3,094 - $4,152
29 Added 1.86%
1,591 $986,000
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $36,202 - $48,244
447 Added 40.09%
1,562 $804,000
Q1 2021

May 14, 2021

BUY
$84.79 - $104.74 $94,540 - $116,785
1,115 New
1,115 $382,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.